Generic Drug

MIAMI, August 7, 2026 NRx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has completed the first-cycle...

Ahmedabad, India / Pennington, New Jersey, August 4, 2026 Zydus Lifesciences Limited has received final approval from the U.S....

ST. LOUIS – July 24, 2026 Par Health, Inc. has announced the U.S. launch of its generic version of...

MUMBAI, India & NAPLES, Fla., May 5, 2026 Lupin Limited, a global pharmaceutical leader, has announced that it has...

Mumbai, India & Naples, Florida | April 10, 2026 Lupin Limited has announced the U.S. launch of Dapagliflozin Tablets...

MUMBAI, India & NAPLES, Fla., USA, March 31, 2026 Lupin Limited has received tentative approval from the U.S. Food...

COLUMBIA, S.C., October 30, 2025 — The Ritedose Corporation has received U.S. Food and Drug Administration (FDA) approval to...